Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Neupogen will be first biologic on FDA biosimilars pathway

US regulator will review Novartis’  version of Amgen's Neupogen (filgrastim) over the coming months

Genentech’s Sunil Agarwal joins rare disease firm

He will serve as chief medical officer at Ultragenyx

- PMLiVE

Connelly Partners acquires Mc|K Healthcare

Advertising firm adds healthcare specialist to roster

- PMLiVE

Managing pharma’s uncertainty

Futures we can’t predict need a strategy we can’t plan

- PMLiVE

Turkey aims to become ‘global player’ in biopharma

Government pledges to boost country’s support for medicines access and R&D

- PMLiVE

FDA approves Gilead drug in three blood cancers

Zydelig recommended for use in chronic lymphocytic leukaemia and two forms of lymphoma

- PMLiVE

BMJ accuses Boehringer of withholding Pradaxa data

Claims current FDA recommendation for anticoagulant may be flawed

- PMLiVE

Philips names head of healthcare for South Asia

Sameer Garde takes role at tech company

- PMLiVE

Community pharmacies central to diabetes fight in UK

Risk assessments can help identify people at risk of developing condition

- PMLiVE

Rare diseases and individualised approaches

Orphan drugs require a more innovative, insightful take on branding strategy

- PMLiVE

Porter Novelli announces new senior health role

New senior VP Amy Nicole Nayar has experience at Pfizer

- PMLiVE

Boehringer goes on PR offensive over Pradaxa report

Takes to social media to defend its position on the anticoagulant ahead of tonight's Channel 4 news report

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links